The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.

NCTNCT01948804Other idytu-123Other idytu-123

Open at ClinicalTrials.govAsk about this trial

Overview

Status: Status unknown
Phase: Phase 4
Enrollment: 100 participants (estimated)
Sponsor: Pınar Özcan Cenksoy · Other
Design: Randomized · Double masking
Countries: Not stated
Start: Jan 2014
Primary completion: Mar 2014 (estimated)
Completion: Not stated
First posted: 24 Sept 2013 (estimated)
Last update posted: 15 Jan 2014 (estimated)
Conditions: Poor Responders Undergoing IVF

Timeline

1 trial

Completed
Ongoing
Not yet recruiting
Stopped
Estimated dates (est.)
Results posted

20142015

Ph 4
The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.
NCT01948804
Jan 2014 to est. Mar 2014 (primary)

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

The comparison of effect of four different treatment protocols: Antagonist/letrozole protocol, microdose flare-up protocol, Antagonist/clomiphene protocol, Antagonist on IVF outcomes in poor responders undergoing in vitro fertilization; a prospective randomized-controlled study.

Interventions

GnrH Antagonist/letrozole protocol (Cetrotide; serono + Femara; Novartis Pharma AG)Drug
microdose flare-up protocol (Lucrin; Abbott + Gonal F, Serono)Drug
Antagonist/clomiphene protocol (Cetrotide; serono + Klomen, Kocak pharma)Drug
GnRH antagonist protocol (Cetrotide, Serono)Drug

Arms1

Experimental
IVF patients
patients that has applied to Yeditepe University Hospital assisted reproduction center

Primary outcomes1

Outcomes the sponsor listed as primary.

clinical pregnancy rates
Time frame · 6 months

Secondary outcomes(1)

total number of oocytes retrieved
Time frame · 6 months

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

A trial that is still running, or that stopped early, may post results later.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex: Female
Age: from 18 Years up to 44 Years
Healthy volunteers: Accepted

Inclusion and exclusion criteria, as posted

Inclusion Criteria: Criteria for definition of poor responders included at least one of the following 1. Anti müllerian hormone \<1.1 ng/ml and/or a previous poor ovarian response (≤3 oocytes with a conventional stimulation protocol). 2. Primary infertile patients 3. BMI≤30 kg/m2 were included this study. Exclusion Criteria: \-

PepBank is a research reference. Talk to a doctor before you use any peptide.